The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Oct 22, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of indoor air pollution, like chemicals and biological substances, can affect the health and wellbeing of school-aged children, particularly those aged 8 to 9 years. Researchers will monitor the air quality in classrooms using advanced sensors and will also gather information about pollution from other sources, such as outdoor air and transportation. The health of the children will be tracked over time using special medical procedures and a fun app that helps them stay engaged.
To participate, children must be in primary school and meet some basic criteria, like having a parent or guardian who can provide consent and understand the study's purpose. Participants will be expected to use the app and follow the study's guidelines. This trial aims to provide important insights into how air quality impacts children's health, which could lead to better environmental policies and healthier school settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Students of primary schools aged 8-9 years.
- • 2. The subject and/or legal custodian have the verbal, writing and mental ability to understand the intent and character of the study.
- • 3. Written informed consent from the child's parents/guardian's
- Exclusion Criteria:
- • Unwilling to use the application and follow the procedures of the protocol
About National And Kapodistrian University Of Athens
The National and Kapodistrian University of Athens is a prestigious academic institution in Greece, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving healthcare outcomes. Its dedicated research teams leverage cutting-edge methodologies and a diverse range of expertise to address critical health challenges. As a clinical trial sponsor, the university prioritizes ethical standards and the welfare of participants, contributing significantly to the global body of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
NIKOLAOS G PAPADOPOULOS, Professor
Study Chair
National and Kapodistrian Univeristy of Athens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials